首页 | 本学科首页   官方微博 | 高级检索  
     


Distinct kinases are involved in contraction of cat esophageal and lower esophageal sphincter smooth muscles
Authors:Kim Nayoung  Cao Weibiao  Song In Sung  Kim Chung Yong  Harnett Karen M  Cheng Ling  Walsh Michael P  Biancani Piero
Affiliation:Department of Medicine, Seoul National University, Bundang Hospital, Seoungnam, Gyeronggi-Do 463-707, Korea.
Abstract:Contraction of smooth muscle depends on the balance of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) activities. Because MLCK activation depends on the activation of calmodulin, which requires a high Ca2+ concentration, phosphatase inhibition has been invoked to explain contraction at low cytosolic Ca2+ levels. The link between activation of the Ca2+-independent protein kinase C{epsilon} (PKC{epsilon}) and MLC phosphorylation observed in the esophagus (ESO) (Sohn UD, Cao W, Tang DC, Stull JT, Haeberle JR, Wang CLA, Harnett KM, Behar J, and Biancani P. Am J Physiol Gastrointest Liver Physiol 281: G467–G478, 2001), however, has not been elucidated. We used phosphatase and kinase inhibitors and antibodies to signaling enzymes in combination with intact and saponin-permeabilized isolated smooth muscle cells from ESO and lower esophageal sphincter (LES) to examine PKC{epsilon}-dependent, Ca2+-independent signaling in ESO. The phosphatase inhibitors okadaic acid and microcystin-LR, as well as an antibody to the catalytic subunit of type 1 protein serine/threonine phosphatase, elicited similar contractions in ESO and LES. MLCK inhibitors (ML-7, ML-9, and SM-1) and antibodies to MLCK inhibited contraction induced by phosphatase inhibition in LES but not in ESO. The PKC inhibitor chelerythrine and antibodies to PKC{epsilon}, but not antibodies to PKC{beta}II, inhibited contraction of ESO but not of LES. In ESO, okadaic acid triggered translocation of PKC{epsilon} from cytosolic to particulate fraction and increased activity of integrin-linked kinase (ILK). Antibodies to the mitogen-activated protein (MAP) kinases ERK1/ERK2 and to ILK, and the MAP kinase kinase (MEK) inhibitor PD-98059, inhibited okadaic acid-induced ILK activity and contraction of ESO. We conclude that phosphatase inhibition potentiates the effects of MLCK in LES but not in ESO. Contraction of ESO is mediated by activation of PKC{epsilon}, MEK, ERK1/2, and ILK. protein kinase C; myosin light chain kinase; phosphatase; integrin-linked kinase
Keywords:
本文献已被 PubMed 等数据库收录!
点击此处可从《American journal of physiology. Cell physiology》浏览原始摘要信息
点击此处可从《American journal of physiology. Cell physiology》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号